日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Broad-Spectrum Antiviral Styrene Maleic-Acid Copolymer Lipid Particle Nanodiscs for pH-Responsive Irreversible Virus Inactivation

用于pH响应型不可逆病毒灭活的广谱抗病毒苯乙烯马来酸共聚物脂质颗粒纳米盘

Hwang, Jaehyeon; Kim, Misoo; Jung, Younghun; Kim, Soomin; Kim, Beom Kyu; Choi, Soyun; Park, Wonbeom; Oh, Hyunseok; Moon, Jeonghui; Yoon, Jeong Hyeon; Kim, Suhyun; Kim, Hwanju; Choo, Hyunjoo; Park, EunKhang; Kim, Min Kyeom; Moon, Seokoh; Yu, Seokhyeon; Jung, Sangwon; Song, Min-Suk; Chung, Woo-Jae; Kweon, Dae-Hyuk

Immunogenicity of the 9-valent human papillomavirus vaccine: Post hoc analysis from five phase 3 studies

9价人乳头瘤病毒疫苗的免疫原性:五项3期研究的事后分析

Giuliano, Anna R; Palefsky, Joel M; Goldstone, Stephen E; Bornstein, Jacob; De Coster, Ilse; Guevara, Ana María; Mogensen, Ole; Schilling, Andrea; Van Damme, Pierre; Vandermeulen, Corinne; Ellison, Misoo C; Kaplan, Susan; Lin, Jianxin; Bonawitz, Rachael; Luxembourg, Alain

Correlation between the Korean Version of the Trunk Control Measurement Scale and the Selective Control Assessment of the Lower Extremity Scores in Children with Cerebral Palsy

韩国版躯干控制测量量表与脑瘫儿童下肢选择性控制评估评分的相关性

Lim, Misoo; Lee, Haneul; Lim, Hyoungwon

Pembrolizumab as First-line Therapy in Cisplatin-ineligible Advanced Urothelial Cancer (KEYNOTE-052): Outcomes in Older Patients by Age and Performance Status

帕博利珠单抗作为不适合顺铂治疗的晚期尿路上皮癌的一线疗法(KEYNOTE-052):老年患者按年龄和体能状态划分的疗效

Grivas, Petros; Plimack, Elizabeth R; Balar, Arjun V; Castellano, Daniel; O'Donnell, Peter H; Bellmunt, Joaquim; Powles, Thomas; Hahn, Noah M; de Wit, Ronald; Bajorin, Dean F; Ellison, Misoo C; Frenkl, Tara L; Godwin, James L; Vuky, Jacqueline

Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

在 MODIFY I/II 研究的癌症患者中,探索性评估 Bezlotoxumab 对艰难梭菌感染相关结局的影响

Cornely, Oliver A; Mullane, Kathleen M; Birch, Thomas; Hazan-Steinberg, Sabine; Nathan, Richard; Bouza, Emilio; Calfee, David P; Ellison, Misoo Chung; Wong, Michael T; Dorr, Mary Beth

Analysis of C. difficile infection-related outcomes in European participants in the bezlotoxumab MODIFY I and II trials

对参与 bezlotoxumab MODIFY I 和 II 试验的欧洲受试者中艰难梭菌感染相关结局的分析

Bouza, Emilio; Cornely, Oliver A; Ramos-Martinez, Antonio; Plesniak, Robert; Ellison, Misoo C; Hanson, Mary E; Dorr, Mary Beth

Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence

Bezlotoxumab 用于预防复发风险增加患者的艰难梭菌感染复发

Gerding, Dale N; Kelly, Ciaran P; Rahav, Galia; Lee, Christine; Dubberke, Erik R; Kumar, Princy N; Yacyshyn, Bruce; Kao, Dina; Eves, Karen; Ellison, Misoo C; Hanson, Mary E; Guris, Dalya; Dorr, Mary Beth

Optimal cutoff value for assessing changes in intrahepatic fat amount by using the controlled attenuation parameter in a longitudinal setting

在纵向研究中,利用受控衰减参数评估肝内脂肪量变化的最佳临界值

Ahn, Sang Bong; Jun, Dae Won; Kang, Bo-Kyeong; Kim, Mimi; Chang, Misoo; Nam, Eunwoo

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women

9价人乳头瘤病毒疫苗在拉丁美洲女孩、男孩和年轻女性中的有效性、免疫原性和安全性

Ruiz-Sternberg, Ángela María; Moreira, Edson D Jr; Restrepo, Jaime A; Lazcano-Ponce, Eduardo; Cabello, Robinson; Silva, Arnaldo; Andrade, Rosires; Revollo, Francisco; Uscanga, Santos; Victoria, Alejandro; Guevara, Ana María; Luna, Joaquín; Plata, Manuel; Dominguez, Claudia Nossa; Fedrizzi, Edison; Suarez, Eugenio; Reina, Julio C; Ellison, Misoo C; Moeller, Erin; Ritter, Michael; Shields, Christine; Cashat, Miguel; Perez, Gonzalo; Luxembourg, Alain

Estimating of hepatic fat amount using MRI proton density fat fraction in a real practice setting

在实际临床环境中利用磁共振质子密度脂肪分数估算肝脏脂肪含量

Lee, Hyeyoung; Jun, Dae Won; Kang, Bo-Kyeong; Nam, Eunwoo; Chang, Misoo; Kim, Mimi; Song, Soonyoung; Yoon, Byung Chul; Lee, Hang Lak; Lee, Oh Young; Choi, Ho Soon; Lee, Kang Nyeong